biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Response to Finallytherock's AGM Worries

<< Previous

Bullboard Posts

Next >>

Comment by chrispion Dec 17, 2021 1:02pm

89 Views

Post# 34241219

RE:RE:RE:RE:Response to Finallytherock's AGM Worries

Unfortunately I am not wrong and it will be you who will holding the bag wondering how you couldn't have been more wrong. Sorry

finallytherock, like I've been encouraging several others on this board to do, sell your shares if you truly think that way. Why would you not sell now if you think we'll only falter from here? You'll also get a tax loss if you do it before year-end. Think about it. There is no logical reason to hold if you truly believe what you have written unless you truly don't believe what you've written.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing